Cargando…

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors

SIMPLE SUMMARY: p90RSK is a downstream effector protein of the MAPK pathway. In many human cancers, the MAPK pathway is constitutively activated due to oncogenic mutations of its components. Consequently, p90RSK is hyperactive and capable of hyper phosphorylating substrates involved in tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maietta, Immacolata, Del Peschio, Francesca, Buonocore, Preziosa, Viscusi, Eleonora, Laudati, Stefano, Iannaci, Giuseppe, Minopoli, Michele, Motti, Maria Letizia, De Falco, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817759/ https://www.ncbi.nlm.nih.gov/pubmed/36612117 http://dx.doi.org/10.3390/cancers15010121

Ejemplares similares

Role of p90RSK in Kidney and Other Diseases
por: Lin, Ling, et al.
Publicado: (2019)

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
por: Moon, Hyeong-Gon, et al.
Publicado: (2012)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Radiation therapy induces immunosenescence mediated by p90RSK
por: Imanishi, Masaki, et al.
Publicado: (2022)

p90Rsk is not involved in cytostatic factor arrest in mouse oocytes
por: Dumont, Julien, et al.
Publicado: (2005)

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
por: Yadahalli, Shilpa, et al.
Publicado: (2019)

Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 Phosphorylation
por: Vu, Hang Thi, et al.
Publicado: (2018)

p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration
por: Samson, Shiela C., et al.
Publicado: (2019)

The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21(WAF1/CIP1)
por: Neise, D, et al.
Publicado: (2013)

Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK)
por: Lucien, Fabrice, et al.
Publicado: (2011)

The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility
por: Artamonov, Mykhaylo, et al.
Publicado: (2013)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90(RSK2)
por: Lim, Sung H, et al.
Publicado: (2013)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2
por: Teufel, Daniel P., et al.
Publicado: (2009)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
por: Li, Ping, et al.
Publicado: (2012)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
por: Bakry, Ola A., et al.
Publicado: (2012)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

Reactivation of p53 via MDM2 inhibition
por: Kim, E S, et al.
Publicado: (2015)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Hsp90β interacts with MDM2 to suppress p53‐dependent senescence during skeletal muscle regeneration
por: He, Min Yi, et al.
Publicado: (2019)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

The p90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line
por: Kim, Han Sang, et al.
Publicado: (2016)

Fibroblast p90RSK induces epithelial transdifferentiation through oxidative stress‐mediated β‐catenin pathway
por: Shi, Chaowen, et al.
Publicado: (2023)

Progesterone inhibition of MDM2 p90 protein in MCF-7 human breast cancer cell line is dependent on p53 levels
por: Alkhalaf, Moussa, et al.
Publicado: (2005)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
por: Frosi, Y., et al.
Publicado: (2019)

Explaining oscillations and variability in the p53-Mdm2 system
por: Proctor, Carole J, et al.
Publicado: (2008)

Targeting the p53–MDM2 interaction to treat cancer
por: Klein, C, et al.
Publicado: (2004)

The Role of p53 and MDM2 in Head and Neck Cancer
por: Denaro, N., et al.
Publicado: (2011)

p53 AND MDM2 PROTEIN EXPRESSION IN ACTINIC CHEILITIS
por: de Freitas, Maria da Conceição Andrade, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dg0qo2241godcrmvjjpinhb0m4